P2.17-27 IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC With Atezolizumab + Chemotherapy
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1553
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV